Literature DB >> 21386794

Advances in osteoclast biology: old findings and new insights from mouse models.

James R Edwards1, Gregory R Mundy.   

Abstract

The maintenance of adequate bone mass is dependent upon the controlled and timely removal of old, damaged bone. This complex process is performed by the highly specialized, multinucleated osteoclast. Over the past 15 years, a detailed picture has emerged describing the origins, differentiation pathways and activation stages that contribute to normal osteoclast function. This information has primarily been obtained by the development and skeletal analysis of genetically modified mouse models. Mice harboring mutations in specific genetic loci exhibit bone defects as a direct result of aberrations in normal osteoclast recruitment, formation or function. These findings include the identification of the RANK-RANKL-OPG system as a primary mediator of osteoclastogenesis, the characterization of ion transport and cellular attachment mechanisms and the recognition that matrix-degrading enzymes are essential components of resorptive activity. This Review focuses on the principal observations in osteoclast biology derived from genetic mouse models, and highlights emerging concepts that describe how the osteoclast is thought to contribute to the maintenance of adequate bone mass and integrity throughout life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21386794     DOI: 10.1038/nrrheum.2011.23

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  96 in total

1.  Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice.

Authors:  Firas M Kara; Stephen B Doty; Adele Boskey; Steven Goldring; Mone Zaidi; Bertil B Fredholm; Bruce N Cronstein
Journal:  Arthritis Rheum       Date:  2010-02

Review 2.  Matrix metalloproteinases and bone.

Authors:  Stephen M Krane; Masaki Inada
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

5.  Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse.

Authors:  S C Marks; P W Lane
Journal:  J Hered       Date:  1976 Jan-Feb       Impact factor: 2.645

6.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

8.  A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Authors:  Hiroaki Ohno; Kazuo Kubo; Hideko Murooka; Yoshiko Kobayashi; Tsuyoshi Nishitoba; Masabumi Shibuya; Toshiyuki Yoneda; Toshiyuki Isoe
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

Review 9.  Human carbonic anhydrases and carbonic anhydrase deficiencies.

Authors:  W S Sly; P Y Hu
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation.

Authors:  W W Wiktor-Jedrzejczak; A Ahmed; C Szczylik; R R Skelly
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more
  94 in total

1.  Bone: Finding that osteoclasts repel osteoblast activity through Sema4D reveals novel target for bone-boosting therapies.

Authors:  Emma Leah
Journal:  Nat Rev Rheumatol       Date:  2011-11-22       Impact factor: 20.543

2.  Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.

Authors:  Kosei Nakajima; Dhong Hyo Kho; Takashi Yanagawa; Yosuke Harazono; Victor Hogan; Wei Chen; Rouba Ali-Fehmi; Rohit Mehra; Avraham Raz
Journal:  Cancer Res       Date:  2016-02-02       Impact factor: 12.701

3.  Good guys gone bad: exTreg cells promote autoimmune arthritis.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Nat Med       Date:  2014-01       Impact factor: 53.440

Review 4.  Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues.

Authors:  Huijuan Liu; Xuechun Xia; Baojie Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-18

Review 5.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

6.  In Focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2019-06       Impact factor: 4.304

7.  Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Authors:  Tingting Luo; Hongrui Liu; Wei Feng; Di Liu; Juan Du; Jing Sun; Wei Wang; Xiuchun Han; Jie Guo; Norio Amizuka; Xianqi Li; Minqi Li
Journal:  Cell Prolif       Date:  2016-11-21       Impact factor: 6.831

Review 8.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

9.  Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways.

Authors:  Xianrong Zhang; Ji Zhu; Yumei Li; Tiao Lin; Valerie A Siclari; Abhishek Chandra; Elena M Candela; Eiki Koyama; Motomi Enomoto-Iwamoto; Ling Qin
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

Review 10.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.